Human medicines European public assessment report (EPAR): Rekovelle, follitropin delta, Date of authorisation: 12/12/2016, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Mirapexin, pramipexole, Date of authorisation: 23/02/1998, Revision: 43, Status: Authorised

Quarterly System Demo - Q2 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 June 2026, 09:00 (CEST) to 25 June 2026, 12:40 (CEST)

CAT quarterly highlights and approved ATMPs - June 2026

Annual reports and work programmes

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 12 May 2026, 09:30 (CEST) to 12 May 2026, 13:30 (CEST)

Committee for Medicinal Products for Veterinary Use (CVMP): 14-16 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 14 April 2026 to 16 April 2026

Clinical evaluation of antifungal agents for the treatment and prophylaxis invasive fungal disease - Scientific guideline

Concept paper on the revision of the guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease

Topamax